PPBT Purple Biotech
- 5.310
- +0.140+2.71%
Purple Biotech News
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | F-1: Registration statement for securities of certain foreign private issuers
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Analysis
Price Target
No Data
No Data